Scientists hail promise of first effective Ebola treatments
Scientists have said they are a step closer to finding the first effective treatments for the Ebola virus after two potential drugs showed survival rates of as much as 90 percent in a clinical trial in the Democratic Republic of the Congo.
Two experimental drugs - Regeneron's REGN-EB3 and a monoclonal antibody called mAb114 - were both developed using antibodies harvested from survivors of the Ebola virus.
They showed better results in patients in a trial of four potential treatments being conducted during the world's second-largest Ebola outbreak in history, now entering its second year in the DRC.
Al Jazeera's Sara Khairat reports.
Dr. William Schaffner of Vanderbilt University talks about two new experimental Ebola treatments with CGTN's Asieh Namdar. The last living survivor of the first ever Navy SEAL team just turned 94 - so CBS News went to meet him and hear the WWII stories only he can tell. The first summit between Russian President Vladimir Putin and the leader of the Democratic People's Republic of Korea Kim Jong Un gets underway on Thursday. Royal baby frenzy is in high-gear as the world waits for the arrival of Prince Harry and Meghan Markle's first child. CBS News royal contributor Victoria Arbiter joined CBSN to discuss.